KFAR SABA, Israel, Oct. 15, 2019 /PRNewswire/ -- CartiHeal, developer of Agili-C™, a proprietary implant for the treatment of cartilage lesions in arthritic and non-arthritic joints, announced today the first implantation of the Agili-C™ implant, as part of Investigational Device Exemption (IDE) clinical study by Dr. Jason M. Scopp, orthopedic surgeon and Director of Joint Preservation Center at Peninsula Orthopaedic Clinic in Salisbury, Maryland. The clinical study will involve a minimum of 250 study patients, currently 241 patients have already been enrolled. You can read more
KFAR SABA, Israel, Oct. 15, 2019 /PRNewswire/ -- CartiHeal, developer of Agili-C™, a proprietary implant for the treatment of cartilage lesions in arthritic and non-arthritic joints, announced today the first implantation of the Agili-C™ implant, as part of Investigational Device Exemption (IDE) clinical study by Dr. Jason M. Scopp, orthopedic surgeon and Director of Joint Preservation Center at Peninsula Orthopaedic Clinic in Salisbury, Maryland. The clinical study will involve a minimum of 250 study patients, currently 241 patients have already been enrolled. You can read more
New WhiteSource for Developers integrations with GitLab Core and Eclipse IDE empower even more enterprise developers to create secure products faster. Read more
New WhiteSource for Developers integrations with GitLab Core and Eclipse IDE empower even more enterprise developers to create secure products faster. Read more
Based in Rehovot, the medical device company has developed a proprietary 355nm wavelength laser technology platform. US medical device company AngioDynamics Inc. (NASDAQ: ANGO) today announced an agreement to acquire Israel laser technology developer Eximo Medical Ltd. for $46 million and up to $20 million in milestone payments.
Based in Rehovot, the medical device company has developed a proprietary 355nm wavelength laser technology platform. US medical device company AngioDynamics Inc. (NASDAQ: ANGO) today announced an agreement to acquire Israel laser technology developer Eximo Medical Ltd. for $46 million and up to $20 million in milestone payments.
